The Position of Multikinase Inhibitors in the Era of Immune-Checkpoint Inhibitors for Hepatocellular Carcinoma

Kim Beom Kyung

Gut and Liver

2024 .01

The prime time for management of hepatocellular carcinoma in Hong Kong

Landon L. Chan ,  Stephen L. Chan

Clinical and Molecular Hepatology

2023 .04

Immune-Checkpoint-Inhibitor-Induced Severe Autoimmune Encephalitis Treated by Steroid and Intravenous Immunoglobulin

김아원 ,  김범석 ,  이순태 외 2명

Journal of Clinical Neurology

2019 .01

The clinical management of hepatocellular carcinoma in China: Progress and challenges

Shan Shan ,  Jidong Jia

Clinical and Molecular Hepatology

2023 .04

Phosphoinositide 3-kinase inhibitors are effective therapeutic drugs for the treatment of hepatocellular carcinoma?

Jeong Su Pa ,  k ,  Soo Han Bae

Clinical and Molecular Hepatology

2020 .01

Advances in immune checkpoint inhibitors for hepatocellular carcinoma

한지원 ,  박수형

Journal of Liver Cancer

2021 .09

Current Status and Future Direction of Immunotherapy in Hepatocellular Carcinoma: What Do the Data Suggest?

Hye Won Lee ,  Kyung Joo Cho ,  Jun Yong Pa 외 1명

Immune Network

2020 .02

Immune-related Adverse Events: Overview and Management Strategies for the Use of Immune Checkpoint Inhibitors

정희철 ,  Se Eung Oh ,  김지형

대한류마티스학회지

2019 .01

How long should physicians follow up with patients after curative treatment for hepatocellular carcinoma?

Bo Hyun Kim

Clinical and Molecular Hepatology

2020 .01

The emerging age-pattern changes of patients with hepatocellular carcinoma in Korea

Yu ,  i Cho ,  Bo Hyun Kim 외 2명

Clinical and Molecular Hepatology

2023 .01

Systemic therapy in advanced hepatocellular carcinoma

Joseph C Ahn ,  Nguyen H. T ,  an 외 1명

Clinical and Molecular Hepatology

2023 .04

The development of alcohol-associated hepatocellular carcinoma mouse model

Wonhyo Seo

한국실험동물학회 학술발표대회 논문집

2022 .07

What should be done to reduce the discrepancy between guidelines and real-life practice for hepatocellular carcinoma in Korea?

Min Kyung Pa ,  k ,  Yoon Jun Kim

Clinical and Molecular Hepatology

2023 .04

Toward user-friendly and evidence-based practice guidelines for hepatocellular carcinoma

Do Young Kim

Clinical and Molecular Hepatology

2023 .04

Breakthroughs in the Systemic Treatment of HER2-Positive Advanced/Metastatic Gastric Cancer: From Singlet Chemotherapy to Triple Combination

Chung Hyun Cheol ,  라선영

Journal of Gastric Cancer

2023 .01

Te Diagnosis and Treatment of Autoimmune Encephalitis

E ,  ic Lancaste

Journal of Clinical Neurology

2016 .01

Effect of autophagy modulation on sorafenib-induced cytotoxicity in hepatocellular carcinoma cells

Yeon Ju Jung ,  Jung A Hong ,  Inki Kim 외 1명

한국실험동물학회 학술발표대회 논문집

2019 .01

Recent Advances and Future Directions in Immunotherapeutics for Hepatocellular Carcinoma

조유리 ,  주소현

Journal of Liver Cancer

2019 .01

Surveillance for hepatocellular carcinoma: It is time to move forward

Bo Hyun Kim ,  Yu ,  i Cho 외 2명

Clinical and Molecular Hepatology

2022 .10

Differential response to immune checkpoint inhibitor in syngeneic gastric cancer mouse models

Dagyeong Lee ,  Joon Yong Choi ,  Hye Jeong Oh 외 4명

대한임상종양학회 학술대회지

2022 .02